Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,856,166
+$652,932 QoQ
Shares Held
47,963
+53.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#167
of 321 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Derivatives in COGT
reported options exposure · as of Jun 30, 2025CallValue
$567,220
CallShares
79,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. COGT ranks #80 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in COGT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,856,166 | 47,963 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,203,234 | 31,261 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,423,443 | 321,606 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,167,158 | 359,830 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $567,220 | 79,000 | Call | Sole | 2026-02-27 | |
| 2025-06-30 | $2,301,655 | 320,565 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $1,047,758 | 174,918 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $1,505,930 | 193,068 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,897,387 | 175,684 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $658,745 | 78,143 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $723,428 | 107,653 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $1,347,725 | 229,205 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $1,081,392 | 110,912 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $1,330,733 | 112,393 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,163,140 | 107,798 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,074,927 | 179,492 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $2,211,979 | 148,256 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $25,102 | 2,783 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $255,723 | 34,142 | Shares | Sole | 2022-05-16 | |
| 2020-06-30 UMRX | — | 7,474 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||